Tramadol Ophthalmic Composition pH Range for Plastic-Container Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a lack of knowledge about the stability of ophthalmic preparations containing tramadol, necessitating a composition with improved stability for ophthalmic use.

Innovation Solution

An ophthalmic composition with a pH of 4.0 to 6.8, containing tramadol or its salt, stored in a plastic container made of materials like polyethylene, polypropylene, or cyclic olefin copolymer, optionally with a buffer, to enhance stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If tramadol is stored in a plastic container for ophthalmic use, then ease of operation and patient comfort are improved, but stability of the composition deteriorates due to unknown interactions between tramadol and plastic materials

Engineering Contradiction:
Improveease of operationVSAvoidstability
Core Design Contradiction:
Ease of operationVSStability of the object's composition

Solution Approach 1:

The patent applies parameter changes by optimizing the pH range to 4.0-6.8 and controlling tramadol concentration at 0.01-10 w/v%, which stabilizes the composition during storage in plastic containers without compromising ease of operation

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces buffering agents as intermediary substances that mediate between the tramadol and plastic container environment, maintaining pH stability and preventing degradation while allowing plastic container use

Inventive Principle:
Principle #24Intermediary (Mediator)

2Stability of the object's composition

If the pH of the ophthalmic composition is adjusted to stabilize tramadol, then stability is improved, but the composition may become less compatible with ocular tissues

Engineering Contradiction:
ImprovestabilityVSAvoidocular compatibility
Core Design Contradiction:
Stability of the object's compositionVSObject-affected harmful factors

Solution Approach 1:

The patent optimizes the pH range to 4.0-6.8, which balances stability requirements with ocular compatibility, ensuring the composition remains stable while avoiding harmful effects on eye tissues

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent applies local quality by adjusting specific parameters (pH and concentration) to create optimal conditions at the molecular level while maintaining overall compatibility with the biological system

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS20250381154A1Ophthalmic composition
Publication Date: 2025.12.18 ROHTO PHARM CO LTD
  • US20250381154A1 patent drawing

AI summary

The present invention relates to an ophthalmic composition containing tramadol or a salt thereof, in which the ophthalmic composition has a pH of 4.0 to 6.8 and is stored in a container in which a portion in contact with the ophthalmic composition is partly or entirely formed of plastic.